Literature DB >> 3134069

Sensitivity of Ph 1 + CFU-GM to human recombinant interferon alpha and gamma alone and in combination.

G Visani1, D Russo, D Damiani, S Rizzi, M R Motta, R M Lemoli, C Poluzzi, R Fanin, E Zuffa, P Tosi.   

Abstract

The in vitro effect of human recombinant interferon alpha (IFN) alone and in combination were studied on granulomonocytic colony forming units (CFU-GM) from the peripheral blood of 10 Ph 1+ chronic myeloid leukemia (CML) patients and from the marrow of 5 normal or non-leukemic subjects. alpha- and gamma-IFN alone determined a slight inhibition on colony growth with a preferential effect on "pure" macrophagic colonies. At maximum concentration (10(4) U/ml) leukemic colony inhibition was 46 +/- 34% for alpha IFN and 43 +/- 19% for gamma IFN. Culture growth with alpha + gamma IFN in combination were significantly inhibited (up to 96 +/- 4%) with a concentration-related effect. Similar results were obtained with normal CFU-GM. The synergism that was found in vitro is probably relevant for the in vivo therapeutic effects of these compounds in CML and suggest that the combination is worth testing in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134069     DOI: 10.1007/bf00320633

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  20 in total

1.  Cytotoxic effects of interferon in vitro on granulocytic progenitor cells.

Authors:  P L Greenberg; S A Mosny
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

2.  Effects of recombinant human interferon gamma on hematopoietic progenitor cell growth.

Authors:  J A Toretsky; N T Shahidi; J L Finlay
Journal:  Exp Hematol       Date:  1986-03       Impact factor: 3.084

3.  Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.

Authors:  H E Broxmeyer; L Lu; E Platzer; C Feit; L Juliano; B Y Rubin
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

4.  Membrane receptors for interleukin 2 on hematopoietic precursors in chronic myeloid leukemia.

Authors:  G Visani; R Delwel; I Touw; F Bot; B Löwenberg
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

5.  Human leukocyte interferon preparation blocks granulopoietic differentiation.

Authors:  D S Verma; G Spitzer; J U Gutterman; A R Zander; K B McCredie; K A Dicke
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

6.  Requirement for IFN gamma in potentiation of interferon's antiviral and anticellular activities: identity of mouse and human systems.

Authors:  W R Fleischmann; L A Schwarz; C M Fleischmann
Journal:  J Interferon Res       Date:  1984

7.  Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.

Authors:  J H Schiller; D S Groveman; S M Schmid; J K Willson; K B Cummings; E C Borden
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

8.  Chronic myelogenous leukaemia: haematological remissions with alpha interferon.

Authors:  M Talpaz; K McCredie; H Kantarjian; J Trujillo; M Keating; J Gutterman
Journal:  Br J Haematol       Date:  1986-09       Impact factor: 6.998

9.  The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.

Authors:  H E Broxmeyer; S Cooper; B Y Rubin; M W Taylor
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

Authors:  M Talpaz; H M Kantarjian; K McCredie; J M Trujillo; M J Keating; J U Gutterman
Journal:  N Engl J Med       Date:  1986-04-24       Impact factor: 91.245

View more
  2 in total

1.  Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma.

Authors:  G Visani; R M Lemoli; P Tosi; F Verlicchi; B Gamberi; A R Cenacchi; R Colombini; M Fogli; D Russo; E Zuffa
Journal:  Blut       Date:  1990-05

2.  Treatment of Ph+ chronic myeloid leukemia by gamma interferon.

Authors:  D Russo; R Fanin; E Zuffa; C Gallizia; M Grazia Michieli; D Damiani; N Testoni; V Pecile; G Visani; R Colombini
Journal:  Blut       Date:  1989-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.